(Table 2). Subjects in the stannous fluoride test group had statistically significantly (P< 0.001) fewer number of bleeding
sites compared to the triclosan/copolymer group with adjusted means (SE) of 4.67 (0.32) and 6.77 (0.32), respectively, that corresponds to a 31% reduction relative to the triclosan/copolymer group (Table 3, Fig. 2). In addition, the 2-month
improvement from baseline in the number of bleeding sites was compared between the two dentifrice groups, and the stannous fluoride test group demonstrated an adjusted mean improvement of 6.35 that was 49% greater (P< 0.001) than that of the triclosan/copolymer group with an adjusted mean improvement of 4.26 (Table 3, Fig. 2).